Drugmakers in race for OTC market

Domestic and foreign drugmakers are vying for a bigger share of domestic OTC market.

UCB Korea, a Korean unit of Belgium based UCB Group, is looking to expand their presence with Zyrtec (cetirizine) by offering various incentives and sales allowance regularly in two seasons every year.

Janssen Korea is also beefing up its Tylenol ER business with incentive tools to cement its dominance in...